Saba Capital Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-250,000
| Closed | -$33.6K | – | 295 |
|
|
2024
Q4 | $33.6K | Hold |
250,000
| – | – | ﹤0.01% | 197 |
|
|
2024
Q3 | $29.3K | Hold |
250,000
| – | – | ﹤0.01% | 232 |
|
|
2024
Q2 | $30.1K | Hold |
250,000
| – | – | ﹤0.01% | 260 |
|
|
2024
Q1 | $35.8K | Hold |
250,000
| – | – | ﹤0.01% | 259 |
|
|
2023
Q4 | $44.4K | Hold |
250,000
| – | – | ﹤0.01% | 297 |
|
|
2023
Q3 | $57.5K | Hold |
250,000
| – | – | ﹤0.01% | 335 |
|
|
2023
Q2 | $47.8K | Hold |
250,000
| – | – | ﹤0.01% | 392 |
|
|
2023
Q1 | $41.3K | Buy |
+250,000
| New | +$41.3K | ﹤0.01% | 538 |
|